FDA’s new voucher awards drive share price gains 

The announcement that FDA had awarded the first set of Commissioner's National Priority Vouchers late Thursday lifted shares of three of the winners.

Disc Medicine Inc. (NASDAQ:IRON) capitalized on the designation of its bitopertin to treat porphyria in an $250 million follow-on priced Tuesday. Shares were sold at $84.00, a 4% discount to Monday’s close but 13% higher than the price before the FDA announcement. At Tuesday’s close of $86.17, shares were up 16% since the announcement, putting the company’s market cap at $3.3 billion...